BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34406985)

  • 21. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.
    Rauschenberg R; Bruns J; Brütting J; Daubner D; Lohaus F; Zimmer L; Forschner A; Zips D; Hassel JC; Berking C; Kaehler KC; Utikal J; Gutzmer R; Terheyden P; Meiss F; Rafei-Shamsabadi D; Kiecker F; Debus D; Dabrowski E; Arnold A; Garzarolli M; Kuske M; Beissert S; Löck S; Linn J; Troost EGC; Meier F
    Eur J Cancer; 2019 Mar; 110():11-20. PubMed ID: 30739835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of melanoma brain metastases in patients treated with immunotherapy.
    Lonser RR; Song DK; Klapper J; Hagan M; Auh S; Kerr PB; Citrin DE; Heiss JD; Camphausen K; Rosenberg SA
    J Neurosurg; 2011 Jul; 115(1):30-6. PubMed ID: 21476810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy in combination with systemic therapies for brain metastases: current status and progress.
    Liu L; Chen W; Zhang R; Wang Y; Liu P; Lian X; Zhang F; Wang Y; Ma W
    Cancer Biol Med; 2020 Nov; 17(4):910-922. PubMed ID: 33299643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Innovations in Radiotherapy and Systemic Treatments With Clinical Outcomes in Patients With Melanoma Brain Metastasis From 2007 to 2016.
    Brastianos HC; Nguyen P; Sahgal A; Eisenhauer EA; Baetz T; Hanna TP
    JAMA Netw Open; 2020 Jul; 3(7):e208204. PubMed ID: 32663310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review.
    Lancellotta V; Del Regno L; Di Stefani A; Fionda B; Marazzi F; Rossi E; Balducci M; Pampena R; Morganti AG; Mangoni M; Lebbe C; Garbe C; Longo C; Schinzari G; Tagliaferri L; Peris K
    Radiol Med; 2022 Jul; 127(7):773-783. PubMed ID: 35606609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanoma brain metastases - Interdisciplinary management recommendations 2020.
    Gutzmer R; Vordermark D; Hassel JC; Krex D; Wendl C; Schadendorf D; Sickmann T; Rieken S; Pukrop T; Höller C; Eigentler TK; Meier F
    Cancer Treat Rev; 2020 Sep; 89():102083. PubMed ID: 32736188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome.
    Wegner RE; Abel S; D'Amico RS; Mehta GU; Sheehan J
    J Neurooncol; 2021 Mar; 152(1):79-87. PubMed ID: 33432380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.
    Rahman R; Cortes A; Niemierko A; Oh KS; Flaherty KT; Lawrence DP; Sullivan RJ; Shih HA
    J Neurooncol; 2018 Jun; 138(2):299-306. PubMed ID: 29453679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Melanoma brain metastases : Treatment options].
    Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
    Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.
    Schmidberger H; Rapp M; Ebersberger A; Hey-Koch S; Loquai C; Grabbe S; Mayer A
    Strahlenther Onkol; 2018 Dec; 194(12):1144-1151. PubMed ID: 30298365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma brain metastases: an unmet challenge in the era of active therapy.
    Gorantla V; Kirkwood JM; Tawbi HA
    Curr Oncol Rep; 2013 Oct; 15(5):483-91. PubMed ID: 23954973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia.
    Hong AM; Waldstein C; Shivalingam B; Carlino MS; Atkinson V; Kefford RF; McArthur GA; Menzies AM; Thompson JF; Long GV
    Eur J Cancer; 2021 Jan; 142():10-17. PubMed ID: 33207293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy.
    Stokes WA; Binder DC; Jones BL; Oweida AJ; Liu AK; Rusthoven CG; Karam SD
    J Neuroimmunol; 2017 Dec; 313():118-122. PubMed ID: 29153603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent Radiosurgery and Immune Checkpoint Inhibition: Improving Regional Intracranial Control for Patients With Metastatic Melanoma.
    Murphy B; Walker J; Bassale S; Monaco D; Jaboin J; Ciporen J; Taylor M; Dai Kubicky C
    Am J Clin Oncol; 2019 Mar; 42(3):253-257. PubMed ID: 30557166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma.
    Wang X; Haaland B; Hu-Lieskovan S; Colman H; Holmen SL
    Cancer Rep (Hoboken); 2021 Dec; 4(6):e1419. PubMed ID: 34137219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the systemic treatment of melanoma brain metastases.
    Glitza Oliva IC; Schvartsman G; Tawbi H
    Ann Oncol; 2018 Jul; 29(7):1509-1520. PubMed ID: 29790899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
    Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS
    Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases.
    Ahmed KA; Freilich JM; Sloot S; Figura N; Gibney GT; Weber JS; Sarangkasiri S; Chinnaiyan P; Forsyth PA; Etame AB; Rao NG
    J Neurooncol; 2015 Mar; 122(1):121-6. PubMed ID: 25519302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER-Medicare analysis.
    Sadetsky N; Hernandez A; Wallick CJ; McKenna EF; Surinach A; Colburn DE
    Cancer Med; 2020 Sep; 9(17):6216-6224. PubMed ID: 32667719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Checkpoint Inhibitor with or without Radiotherapy in Melanoma Patients with Brain Metastases: A Systematic Review and Meta-Analysis.
    Kim PH; Suh CH; Kim HS; Kim KW; Kim DY; Lee EQ; Aizer AA; Guenette JP; Huang RY
    Korean J Radiol; 2021 Apr; 22(4):584-595. PubMed ID: 33289357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.